EX-23 7 htgm-ex23_1.htm EX-23.1 EX-23

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

HTG Molecular Diagnostics, Inc.

Tucson, Arizona

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S‑1 (No. 333-268681), Form S3 (Nos. 333-262357 and 333-264210) and Form S-8 (Nos. 333-203930, 333-208325, 333-210401, 333-216942, 333-222571, 333-229303, 333-231349, 333-235961, 333-248207, 333-252142 and 333-258977) of HTG Molecular Diagnostics, Inc. of our report dated March 30, 2023, relating to the consolidated financial statements, which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

 

 

/s/ BDO USA, LLP

 

Los Angeles, California

March 30, 2023